Catheter Precision, Inc. Cash Flow Statement
VTAK|8 years of annual SEC 10-K data (FY2018-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 8 fiscal years. All figures from audited SEC 10-K filings.
Catheter Precision, Inc. used $9M in operating cash flow and negative free cash flow of $9M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.00 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$16.6M | -$70.6M | -$26.9M | -$25.1M | -$36.0M | -$57.0M | -$30.8M | -$17.8M |
| Depreciation & Amortization | $2.1M | $2.1M | $421.0K | $1.6M | $2.4M | $1.8M | $624.0K | $218.0K |
| Operating Cash Flow | -$9.3M | -$20.6M | -$22.6M | -$27.6M | -$28.3M | -$33.2M | -$18.5M | -$5.5M |
| Capital Expenditures | $67.0K | $76.0K | $17.0K | $265.0K | $67.0K | $268.0K | $582.0K | $547.0K |
| Free Cash Flow | -$9.3M | -$20.7M | -$22.6M | -$27.9M | -$28.4M | -$33.4M | -$19.1M | -$6.1M |
| FCF Margin | -2223.3% | -4682.1% | -161321.4% | -126772.7% | -10954.0% | -464.5% | -305.1% | -103.4% |